A phase I / II trial of intraperitoneal paclitaxel and carboplatin after cytoreductive surgery for the treatment of patients with ovarian carcinoma with peritoneal carcinosis or primary peritoneal carcinomatosis. En fase I / II forsog med intraperitoneal Paclitaxel og Carboplatin efter cytoreduktiv operation som behandling af Patienter med ovarie carcinoma med peritoneal carcinose eller primaer peritoneal carcinomatose

Trial Profile

A phase I / II trial of intraperitoneal paclitaxel and carboplatin after cytoreductive surgery for the treatment of patients with ovarian carcinoma with peritoneal carcinosis or primary peritoneal carcinomatosis. En fase I / II forsog med intraperitoneal Paclitaxel og Carboplatin efter cytoreduktiv operation som behandling af Patienter med ovarie carcinoma med peritoneal carcinose eller primaer peritoneal carcinomatose

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 10 Dec 2012

At a glance

  • Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
  • Indications Ovarian cancer; Peritoneal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top